Patrick Ryan

Citado por

	Total	Desde 2019
Citas	14601	11181
Índice h	61	52
Índice i10	194	170

2300

1150

575

1725

2012201320142015201620172018201920202021202220232024127 326 375 449 507 554 786 1001 1512 2181 2285 2135 2023

Acceso público

Ver todo

168 artículos

18 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Martijn SchuemieJanssen R&DDirección de correo verificada de ohdsi.org
George HripcsakColumbia UniversityDirección de correo verificada de columbia.edu
Marc A. SuchardProfessor, University of California, Los AngelesDirección de correo verificada de ucla.edu
David MadiganProfessor of Statistics, Northeastern UniversityDirección de correo verificada de northeastern.edu
Nigam ShahProfessor of Medicine, and Biomedical Data Science, Stanford UniversityDirección de correo verificada de stanford.edu
Rae Woong ParkProfessor of Department of Biomedical Informatics, Ajou University School of MedicineDirección de correo verificada de ajou.ac.kr
Chunhua WengProfessor, Columbia UniversityDirección de correo verificada de columbia.edu
Frank J DeFalcoJanssen Research & DevelopmentDirección de correo verificada de its.jnj.com
Jesse A BerlinVP, Epidemiology, Janssen Research and DevelopmentDirección de correo verificada de its.jnj.com
Erica A VossJanssen Research & DevelopmentDirección de correo verificada de its.jnj.com
Nicholas P TatonettiProfessor and Vice Chair of Computational Biomedicine, Cedars-Sinai Medical CenterDirección de correo verificada de cshs.org
Rave HarpazArchitect/Applied Scientist of AI - Oracle Cloud InfrastructureDirección de correo verificada de oracle.com
Niklas NorénChief Science Officer, Uppsala Monitoring Centre, WHO Collaborating Centre for International DrugDirección de correo verificada de who-umc.org
M. Soledad CepedaJanssen Research & DevelopmentDirección de correo verificada de its.jnj.com
Qianli MaResearch Science Lead, HumanaDirección de correo verificada de humana.com
Richard D BoyceAssociate Professor of Biomedical Informatics, University of PittsburghDirección de correo verificada de pitt.edu
Shawn E. SimpsonColumbia UniversityDirección de correo verificada de stat.columbia.edu
Paea LePenduUniversity of California, RiversideDirección de correo verificada de ucr.edu
Andrew BateGSK, LSHTMDirección de correo verificada de gsk.com
Sebastian Schneeweiss, M.D., Sc.D.Professor of Medicine and Epidemiology, Harvard Medical SchoolDirección de correo verificada de post.harvard.edu

Seguir

Patrick Ryan

Janssen Research and Development

Dirección de correo verificada de cornell.edu

Pharmacovigilance Epidemiology Statistics Medical Informatics


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers G Hripcsak, JD Duke, NH Shah, CG Reich, V Huser, MJ Schuemie, ... MEDINFO 2015: eHealth-enabled Health, 574-578, 2015	1243	2015
Validation of a common data model for active safety surveillance research JM Overhage, PB Ryan, CG Reich, AG Hartzema, PE Stang Journal of the American Medical Informatics Association 19 (1), 54-60, 2012	530	2012
A harmonized data quality assessment terminology and framework for the secondary use of electronic health record data MG Kahn, TJ Callahan, J Barnard, AE Bauck, J Brown, BN Davidson, ... Egems 4 (1), 2016	471	2016
Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership PE Stang, PB Ryan, JA Racoosin, JM Overhage, AG Hartzema, C Reich, ... Annals of internal medicine 153 (9), 600-606, 2010	462	2010
Novel data‐mining methodologies for adverse drug event discovery and analysis R Harpaz, W DuMouchel, NH Shah, D Madigan, P Ryan, C Friedman Clinical Pharmacology & Therapeutics 91 (6), 1010-1021, 2012	445	2012
Characterizing treatment pathways at scale using the OHDSI network G Hripcsak, PB Ryan, JD Duke, NH Shah, RW Park, V Huser, MA Suchard, ... Proceedings of the National Academy of Sciences 113 (27), 7329-7336, 2016	361	2016
Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis MA Suchard, MJ Schuemie, HM Krumholz, SC You, RJ Chen, N Pratt, ... The Lancet 394 (10211), 1816-1826, 2019	332	2019
Performance of pharmacovigilance signal‐detection algorithms for the FDA adverse event reporting system R Harpaz, W DuMouchel, P LePendu, A Bauer‐Mehren, P Ryan, ... Clinical Pharmacology & Therapeutics 93 (6), 539-546, 2013	325	2013
Feasibility and utility of applications of the common data model to multiple, disparate observational health databases EA Voss, R Makadia, A Matcho, Q Ma, C Knoll, M Schuemie, FJ DeFalco, ... Journal of the American Medical Informatics Association 22 (3), 553-564, 2015	302	2015
Feasibility of using real-world data to replicate clinical trial evidence VL Bartlett, SS Dhruva, ND Shah, P Ryan, JS Ross JAMA network open 2 (10), e1912869-e1912869, 2019	227	2019
Interpreting observational studies: why empirical calibration is needed to correct p‐values MJ Schuemie, PB Ryan, W DuMouchel, MA Suchard, D Madigan Statistics in medicine 33 (2), 209-218, 2014	224	2014
Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non‐SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 … PB Ryan, JB Buse, MJ Schuemie, F DeFalco, Z Yuan, PE Stang, JA Berlin, ... Diabetes, Obesity and Metabolism 20 (11), 2585-2597, 2018	221	2018
A curated and standardized adverse drug event resource to accelerate drug safety research JM Banda, L Evans, RS Vanguri, NP Tatonetti, PB Ryan, NH Shah Scientific data 3 (1), 1-11, 2016	219	2016
Evaluating the impact of database heterogeneity on observational study results D Madigan, PB Ryan, M Schuemie, PE Stang, JM Overhage, ... American journal of epidemiology 178 (4), 645-651, 2013	209	2013
Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data JM Reps, MJ Schuemie, MA Suchard, PB Ryan, PR Rijnbeek Journal of the American Medical Informatics Association 25 (8), 969-975, 2018	199	2018
Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership PB Ryan, D Madigan, PE Stang, J Marc Overhage, JA Racoosin, ... Statistics in medicine 31 (30), 4401-4415, 2012	196	2012
Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled … JCE Lane, J Weaver, K Kostka, T Duarte-Salles, MTF Abrahao, H Alghoul, ... MedRxiv, 2020	175	2020
Challenges with quality of race and ethnicity data in observational databases FCG Polubriaginof, P Ryan, H Salmasian, AW Shapiro, A Perotte, ... Journal of the American Medical Informatics Association 26 (8-9), 730-736, 2019	172	2019
Criteria2Query: a natural language interface to clinical databases for cohort definition C Yuan, PB Ryan, C Ta, Y Guo, Z Li, J Hardin, R Makadia, P Jin, N Shang, ... Journal of the American Medical Informatics Association 26 (4), 294-305, 2019	162	2019
Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study X Li, A Ostropolets, R Makadia, A Shoaibi, G Rao, AG Sena, ... bmj 373, 2021	160	2021

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores